BIOMARIN PHARMACEUTICAL INC Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One
BIOMARIN PHARMACEUTICAL INC (BMRN) had Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One of $840.27 million as of 2017-12-31, per its 10-K filed 2018-02-26.
Discontinued › Notes › Investments › Available-for-Sale Securities, Debt Maturities › Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value
us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue · last filed 2018-02-26
- 2017-12-31: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $840.27M.
- 2017-09-30: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $825.70M.
- 2017-06-30: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $374.62M.
- 2017-03-31: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $329.82M.
| Period end | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One as first filed |
|---|---|---|
| 2017-12-31 | $840.27M 10-K · filed 2018-02-26 | |
| 2017-09-30 | $825.70M 10-Q · filed 2017-10-31 | |
| 2017-06-30 | $374.62M 10-Q · filed 2017-08-02 | |
| 2017-03-31 | $329.82M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $395.94M 10-K · filed 2018-02-26 | $381.35M 10-K · filed 2017-02-27 |
| 2016-09-30 | $327.50M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $197.32M 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $186.40M 10-Q · filed 2016-05-02 | |
| 2015-12-31 | $195.58M 10-K · filed 2017-02-27 | |
| 2015-09-30 | $241.98M 10-Q · filed 2015-11-02 | |
| 2015-06-30 | $240.89M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $108.12M 10-Q · filed 2015-05-05 | |
| 2014-12-31 | $69.71M 10-K · filed 2016-02-29 | |
| 2014-09-30 | $268.37M 10-Q · filed 2014-10-28 | |
| 2014-06-30 | $251.90M 10-Q · filed 2014-07-31 | |
| 2014-03-31 | $247.70M 10-Q · filed 2014-05-02 | |
| 2013-12-31 | $215.94M 10-K · filed 2015-03-02 | |
| 2013-09-30 | $198.09M 10-Q · filed 2013-10-28 | |
| 2013-06-30 | $225.12M 10-Q · filed 2013-07-29 | |
| 2013-03-31 | $247.50M 10-Q · filed 2013-04-29 | |
| 2012-12-31 | $267.28M 10-K · filed 2014-02-26 | $270.21M 10-Q · filed 2013-04-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |